PMID: 9166733Jun 1, 1997Paper

A constitutively internalizing and recycling mutant of the mu-opioid receptor

Journal of Neurochemistry
V SegredoW Sadée

Abstract

Internalization and recycling of G protein-coupled receptors (GPCRs), such as the mu-opioid receptor, largely depend on agonist stimulation, whereas certain other receptor types recycle constitutively, e.g., the transferrin receptor. To investigate structural domains involved in mu-opioid receptor internalization, we constructed two truncation mutants bracketing a Ser/Thr-rich domain (354ThrSerSerThrIleGluGlnGlnAsn362) unique to the C-terminus of the mu-opioid receptor (mutants Trunc354 and Trunc363). Ligand binding did not differ substantially, and G protein coupling was slightly lower for these mu-receptor constructs, in particular for Trunc363. To permit localization of the receptor by immunocytochemistry, an epitope tag was added to the N-terminus of the wild-type and mutant receptors. Both the wild-type mu-opioid receptor and Trunc363 resided largely at the plasma membrane and internalized into vesicles upon stimulation with the agonist [D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin. Internalization occurred into vesicles that contain transferrin receptors, as shown previously, as well as clathrin, but not caveolin. In contrast, even without any agonist present, Trunc354 colocalized in intracellular vesicles with clathrin and trans...Continue Reading

Citations

Sep 17, 1998·The Journal of Biological Chemistry·S R MurrayM von Zastrow
Mar 18, 2000·The Journal of Biological Chemistry·Y AbeK Goto
Dec 1, 2001·The Journal of Biological Chemistry·Stéphanie Miserey-LenkeiEric Clauser
Apr 12, 2003·Pharmacology & Toxicology·Zsuzsanna Wiesenfeld-HallinTomas Hökfelt
Jun 11, 2004·Annual Review of Biochemistry·Maria WaldhoerJennifer L Whistler
Jul 31, 1999·Journal of Neurochemistry·C HsiehK Mackie
Jun 13, 2003·American Journal of Physiology. Cell Physiology·Richard BouleyDennis A Ausiello
Mar 29, 2013·Molecular Biology of the Cell·Amanda L Soohoo, Manojkumar A Puthenveedu
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·J ZhangM G Caron
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Dinesh SrinivasanJohn W Regan
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·P Y LawH H Loh
Sep 25, 2001·Neuroreport·C Abbadie, G W Pasternak
May 8, 2000·DNA and Cell Biology·N TrapaidzeL A Devi
Jun 16, 2017·Molecular Biology of the Cell·Yukari Okamoto, Sojin Shikano
Dec 12, 2001·Neuroscience·E J Van Bockstaele, K G Commons
Dec 29, 1999·Brain Research·Z Wiesenfeld-HallinT Hökfelt
Nov 8, 2001·European Journal of Pharmacology·Z Wiesenfeld-Hallin, X J Xu
Aug 26, 1998·Drug and Alcohol Dependence·H AkilS Watson
Dec 16, 1998·Trends in Biochemical Sciences·R LeursH Timmerman
Apr 29, 1998·Trends in Pharmacological Sciences·S D BryantL H Lazarus
Apr 14, 2000·Brain Research. Molecular Brain Research·N TrapaidzeL A Devi
Jul 18, 2006·Cellular Signalling·Graciela Piñeyro, Elodie Archer-Lahlou
Jan 26, 2006·BMC Pharmacology·Parham GharagozlouJelveh Lameh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.